Pregabalin Capsule
Product Images NDC 71610-754
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
Figure 10 (Pregabalin Fig09)
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
The text provides information about the percent of subjects improved. It shows a range of numbers from 100 to 210, along with numbers from 220 to 270. The following text mentions "Percent Improved from Baseline to Week 16 BOCF" and lists "Pregabalin" and "Placebo." The last line of text lists the numbers 280 and 200.*
Figure 13 (Pregabalin Fig13)
This text provides data on the Responder Rate, expressed as a percentage. The values range from 60% to 22.6%. Additionally, there is mention of a placebo dosage of 2.5 mg/kg/day and 10 mg/kg/day. The last line appears to show three numbers: 93, 103, and 9%, though their specific context is unclear.*
Cockcroft And Gault Equation (Pregabalin Formula)
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.